Literature DB >> 26046666

Values of the Minimal Clinically Important Difference for the Neuropsychiatric Inventory Questionnaire in Individuals with Dementia.

Hui-Fen Mao1, Chun-An Kuo1, Wen-Ni Huang2, Jeffrey L Cummings3, Tzung-Jeng Hwang4.   

Abstract

OBJECTIVES: To estimate the minimal clinically important difference (MCID) for the Neuropsychiatric Inventory Questionnaire (NPI-Q), a widely used measure of behavioral and psychological symptoms of dementia (BPSDs) and associated caregiver stress.
DESIGN: Ten registered nurses rated the severity of BPSDs and caregiver distress using the NPI-Q during six monthly assessments and an external reference, a 7-point Likert-type global rating of BPSDs change during five monthly assessments from the second to the sixth month. An anchor-based (global ratings of change) approach and a distribution-based (standard error of measurement) approach were used to determine the MCID for the NPI-Q severity and distress subscales.
SETTING: Long-term care facility. PARTICIPANTS: Nonbedridden residents with dementia (n = 45) and registered nurses (n = 10). MEASUREMENTS: NPI-Q (severity and caregiver distress subscales) and global ratings of changes in BPSDs on a 7-point Likert-type scale.
RESULTS: The NPI-Q MCID ranges were 2.77 to 3.18 for severity and 3.10 to 3.95 for distress. Residents in the highest NPI-Q tertile at baseline had higher MCID severity (3.62) and distress (5.08) scores than those in the lowest tertile (severity (2.40), distress (3.10)).
CONCLUSION: This study provides an estimate of the MCID for severity and distress subscales of the NPI-Q, which can help clinicians and researchers determine whether NPI-Q change scores within a group of individuals with dementia are beyond measurement error and are clinically important.
© 2015, Copyright the Authors Journal compilation © 2015, The American Geriatrics Society.

Entities:  

Keywords:  Neuropsychiatric Inventory Questionnaire (NPI-Q); behavioral and psychological symptoms of dementia (BPSDs); dementia; minimal clinically important difference

Mesh:

Year:  2015        PMID: 26046666     DOI: 10.1111/jgs.13473

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   5.562


  10 in total

1.  Patient and Caregiver Benefit From a Comprehensive Dementia Care Program: 1-Year Results From the UCLA Alzheimer's and Dementia Care Program.

Authors:  David B Reuben; Zaldy S Tan; Tahmineh Romero; Neil S Wenger; Emmett Keeler; Lee A Jennings
Journal:  J Am Geriatr Soc       Date:  2019-07-29       Impact factor: 5.562

2.  D-CARE: The Dementia Care Study: Design of a Pragmatic Trial of the Effectiveness and Cost Effectiveness of Health System-Based Versus Community-Based Dementia Care Versus Usual Dementia Care.

Authors:  David B Reuben; Thomas M Gill; Alan Stevens; Jeff Williamson; Elena Volpi; Maya Lichtenstein; Lee A Jennings; Zaldy Tan; Leslie Evertson; David Bass; Lisa Weitzman; Martie Carnie; Nancy Wilson; Katy Araujo; Peter Charpentier; Can Meng; Erich J Greene; James Dziura; Jodi Liu; Erin Unger; Mia Yang; Katherine Currie; Kristin M Lenoir; Aval-NaʼRee S Green; Sitara Abraham; Ashley Vernon; Rafael Samper-Ternent; Mukaila Raji; Roxana M Hirst; Rebecca Galloway; Glen R Finney; Ilene Ladd; Alanna Kulchak Rahm; Pamela Borek; Peter Peduzzi
Journal:  J Am Geriatr Soc       Date:  2020-10-06       Impact factor: 5.562

3.  Overwhelmed: a Dementia Caregiver Vital Sign.

Authors:  David B Reuben; Tahmineh Romero; Leslie Chang Evertson; Lee A Jennings
Journal:  J Gen Intern Med       Date:  2021-08-13       Impact factor: 6.473

4.  Effectiveness of "Reducing Disability in Alzheimer's Disease" Among Dyads With Moderate Dementia.

Authors:  Jaime Perales-Puchalt; Kelli Barton; Lauren Ptomey; Michelle Niedens; Amy Yeager; Laura Gilman; Pam Seymour; Amanda George; Susan Sprague; Antonio Mirás Neira; Rik Van Dyke; Linda Teri; Eric D Vidoni
Journal:  J Appl Gerontol       Date:  2020-07-01

5.  Caregiver outcomes of a dementia care program.

Authors:  Leslie Chang Evertson; Lee A Jennings; David B Reuben; Kassandra E Zaila; Nadia Akram; Tahmineh Romero; Zaldy S Tan
Journal:  Geriatr Nurs       Date:  2021-03-11       Impact factor: 2.361

6.  Use of cannabinoid-based medicine among older residential care recipients diagnosed with dementia: study protocol for a double-blind randomised crossover trial.

Authors:  Amanda Timler; Caroline Bulsara; Max Bulsara; Alistair Vickery; Jill Smith; Jim Codde
Journal:  Trials       Date:  2020-02-14       Impact factor: 2.279

7.  HOMESIDE: home-based family caregiver-delivered music and reading interventions for people living with dementia: protocol of a randomised controlled trial.

Authors:  Felicity Anne Baker; Jodie Bloska; Sabine Braat; Anna Bukowska; Imogen Clark; Ming H Hsu; Tone Kvamme; Nicola Lautenschlager; Young-Eun Claire Lee; Agnieszka Smrokowska-Reichmann; Tanara Vieira Sousa; Karette A Stensaeth; Jeanette Tamplin; Thomas Wosch; Helen Odell-Miller
Journal:  BMJ Open       Date:  2019-11-19       Impact factor: 2.692

8.  Implementing Affordable Socially Assistive Pet Robots in Care Homes Before and During the COVID-19 Pandemic: Stratified Cluster Randomized Controlled Trial and Mixed Methods Study.

Authors:  Hannah Bradwell; Katie J Edwards; Rhona Winnington; Serge Thill; Victoria Allgar; Ray B Jones
Journal:  JMIR Aging       Date:  2022-08-24

9.  Blood pressure, antihypertensive medication and neuropsychiatric symptoms in older people with dementia: The COSMOS study.

Authors:  Bianca E M de Jong-Schmit; Rosalinde K E Poortvliet; Stefan Böhringer; Jonathan M K Bogaerts; Wilco P Achterberg; Bettina S Husebo
Journal:  Int J Geriatr Psychiatry       Date:  2020-10-08       Impact factor: 3.485

10.  Determining minimal important change for the thyroid-related quality of life questionnaire ThyPRO.

Authors:  Selma Flora Nordqvist; Victor Brun Boesen; Åse Krogh Rasmussen; Ulla Feldt-Rasmussen; Laszlo Hegedüs; Steen Joop Bonnema; Per Karkov Cramon; Torquil Watt; Mogens Groenvold; Jakob Bue Bjorner
Journal:  Endocr Connect       Date:  2021-03       Impact factor: 3.335

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.